Significant gaps in hepatitis B vaccination in adults in Viet Nam: Important targets toward hepatitis B elimination by 2030

被引:1
|
作者
V. Kim, Thanh [1 ,2 ]
Pham, Trang N. D. [3 ,4 ]
Le, Duc H. [1 ]
Dao, Diem V. B. [4 ]
Phan, Loc T. B. [4 ]
Le, Anh [4 ]
Trang, Amy [4 ]
Tang, Hong K. [1 ]
Liu, Jason J. [2 ,5 ,7 ]
Dao, Doan Y. [4 ,6 ,8 ]
机构
[1] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam
[2] Natl Yang Ming Chiao Tung Univ, Coll Med, Int Hlth Program, Taipei, Taiwan
[3] Univ Illinois, Sch Publ Hlth, Chicago, IL USA
[4] Vietnam Viral Hepatitis Alliance, Reston, VA USA
[5] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei, Taiwan
[6] Johns Hopkins Univ, Ctr Excellence Liver Dis Viet Nam, Sch Med, Baltimore, MD USA
[7] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Med Bldg II,155,Sect 2,Linong St, Taipei, Taiwan
[8] Johns Hopkins Univ, Sch Med, Ross Res Bldg,Room 310,720 Rutland Ave, Baltimore, MD 21205 USA
关键词
Hepatitis B virus; Vaccination; Elimination; Survey; Adult; Viet Nam; Lower-middle-income country; INFECTION; VIRUS;
D O I
10.1016/j.vaccine.2022.12.051
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Gaps in adult hepatitis B vaccination were undefined in Vietnam, a lower-middle-income country. To address these gaps, this study defined hepatitis B vaccine coverage in adults and its associated factors in Ho Chi Minh City (HCMC), Viet Nam. We also proposed interventional strategies, prioritizing gap identification to facilitate hepatitis B elimination by 2030 and beyond.Method: During 2019-2020, a multi-stage cluster serosurvey with probability proportional to size was conducted to representatively invite 20,000 adults (18 years or older) throughout HCMC for hepatitis B screening (HBsAg, anti-HBs, and anti-HBc). Serologic results defined two dependent variables: vaccine -induced immunity (i.e., isolated anti-HBs) and susceptibility (i.e., HBV naive). Associations of dependent variables with surveyed demographics, socioeconomic statuses, behaviors, and medical history at risk for hepatitis B were evaluated using weighted Poisson regression.Results: The prevalence was 18.5% (95%CI, 17.3-20.0%) for vaccine-induced immunity and 37.7% (35.6-39.8%) for susceptibility. Even though analyses in the general population revealed a falling trend in vaccine-induced immunity prevalence from younger to older age groups, sensitivity analyses in the non-infected population (i.e., those who were both negative for HBsAg and anti-HBc) showed that younger age groups, especially those aged 30 to 50 years, had the lowest prevalence. Social inequalities existed in different ethnicities, residence areas, education levels, house ownership, and health insurance statuses. There was no significant association between vaccine-induced immunity or susceptibility and risky behaviors and medical histories.Conclusion: This study depicts a significant unmet need for hepatitis B vaccination in the general adult population in HCMC, Viet Nam. Indeed, the lack of vaccination was unevenly distributed regarding age groups, geographical areas, and socioeconomic statuses, which reveals profound social disparities. Therefore, to achieve hepatitis B elimination goals, besides the current recommendations for infants and risk-based strategies, hepatitis B vaccination should be recommended for the broader population.(c) 2022 Elsevier Ltd. All rights reserved.
引用
收藏
页码:976 / 988
页数:13
相关论文
共 50 条
  • [41] ATTITUDE OF HOSPITAL PERSONNEL TOWARD HEPATITIS-B VACCINATION
    SCAPA, E
    KARPUCH, J
    WARON, M
    ESHCHAR, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1989, 84 (04): : 400 - 402
  • [42] Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas
    Alvarez, Alba Maria Ropero
    Perez-Vilar, Silvia
    Pacis-Tirso, Carmelita
    Contreras, Marcela
    El Omeiri, Nathalie
    Ruiz-Matus, Cuauhtemoc
    Velandia-Gonzalez, Martha
    BMC PUBLIC HEALTH, 2017, 17
  • [43] Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas
    Alba Maria Ropero Álvarez
    Silvia Pérez-Vilar
    Carmelita Pacis-Tirso
    Marcela Contreras
    Nathalie El Omeiri
    Cuauhtémoc Ruiz-Matus
    Martha Velandia-González
    BMC Public Health, 17
  • [44] Vaccine-preventabte hepatitis, a step toward elimination reevaluating hepatitis A and B prevention - Introduction
    Schiff, ER
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 : 1 - 6
  • [45] Hepatitis B vaccination status among healthy adults in Germany
    Ringwald, Juergen
    Mertz, Iris
    Zimmermann, Robert
    Weisbach, Volker
    Rabe, Christina
    Strasser, Erwin
    Seyboth, Susanne
    Eckstein, Reinhold
    HEALTH POLICY, 2006, 79 (2-3) : 306 - 312
  • [46] Hepatitis B and A vaccination in HIV-infected adults: A review
    Mena, G.
    Garcia-Basteiro, A. L.
    Bayas, J. M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (11) : 2582 - 2598
  • [47] Socioeconomic inequality in Hepatitis B vaccination of rural adults in China
    Zhu, Dawei
    Guo, Na
    Wang, Jian
    Nicholas, Stephen
    Wang, Zhen
    Zhang, Guojie
    Shi, Luwen
    Wangen, Knut Reidar
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (02) : 464 - 470
  • [48] Significant reduction in Hepatitis B virus infections following 32 years of universal Hepatitis B vaccination as part of EPI, Thailand
    Nilyanimit, Pornjarim
    Wanlapakorn, Nasamon
    Vichaiwattana, Preeyaporn
    Wongsrisang, Lakkhana
    Klinfueng, Sirapa
    Suntronwong, Nungruthai
    Bhunyakitikorn, Wichan
    Angsuwatcharakon, Piyada
    Sonthichai, Chaninan
    Thawinwisan, Narong
    Puedkuntod, Pichet
    Phattharasrivongchai, Sunsanee
    Loprakhon, Parichaya
    Tinnaitorn, Watcharanan
    Luankaew, Thawatchai
    Vinothai, Sasithorn
    Chaijaroen, Somjet
    Meechin, Pornsawan
    Pongpichit, Chalermpol
    Poovorawan, Yong
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [49] Progress toward elimination of hepatitis B virus transmission in the United States
    Mast, EE
    Mahoney, FJ
    Alter, MJ
    Margolis, HS
    VACCINE, 1998, 16 : S48 - S51